Products
CPI-203 1446144-04-2
1.Inquiries will be replied within 24 hours |
2.We could supply various packages as you required |
3.To protect the profit of our agents, price will not show on website, please send inquiries to get the price. |
4.Fast delivery, goods arrive your office within 3 to 5 days |
5.Please click "Inquiry" or "Email" below to get the price |
![]() |
|
|
||||||
|
C19H18ClN5OS |
|
|||||
|
399.90 |
|
in stock | ||||
|
1446144-04-2 |
|
98%+ |
Introduction
CPI-203 is a potent BET bromodomain inhibitor with IC50 of 37 nM for BRD4.
CPI203 inhibits BRD4 in vitro and in cells, while does not affect BRD4 kinase activity in vitro. [1] CPI203 exerts a cytostatic effect in all the 9 MCL cell lines analyzed with GI50 ranging from 0.06 to 0.71 μM, with low cytotoxicity in normal PBMCs from healthy donors. Furthermore, lenalidomide and CPI203, by targeting IRF4 and MYC, efficiently activates the cell death program in MCL cells resistant to bortezomib. [2]
Products for scientific research use only